Mervyn Chan ¤Ñ¨ÏÅ]°­¤é°O
¤Ñ¨Ï©MÅ]°­~¥i¯à¥u¬O¤@½u¤§®t
mervyn
¼ÊºÙ¡G ·ù
©Ê§O¡G ¨k
°ê®a¡G ­»´ä
« June 2026 »
SMTWTFS
123456
78910111213
14151617181920
21222324252627
282930
³Ì·s¤å³¹
Nippon Karate Tenor ...
¤j´¼­Y·M
¬J¥Í·ì¡A¦ó¥Í«G
¯¬¤j®a½Þ¦~§Ö¼Ö
¯¬¦U¦ì±¡¤H¸`§Ö¼Ö
¤å³¹¤ÀÃþ
¥þ³¡ (201)
2003 SARS (1)
Âå¾Ç¥æ¬y (12)
¤À¨É (102)
¤H¥ÍÆ[ (5)
¤jÁp·ù (5)
¤u§@¤é°O (6)
¥»¦a¬y¦æ­µ¼Ö (2)
¦L«×¸q¤u¤§®È (1)
§Úªº¤p»¡³Ð§@ (1)
§Úªº¥Í¬¡ (14)
§Úªº·R±¡Æ[ (1)
§Ú³ß·Rªººq¦± (21)
§Ú´¿ºt¥Xªººq¼@ (5)
ªB¤Í (1)
ªk«ß±`ÃÑ (4)
®a¤H (4)
°·±d¥Í¬¡ (7)
·Å¬Gª¾·s~Revision (1)
¸q¤u (7)
¸t½Ï­µ¼Ö (1)
³X«È¯d¨¥
³Ìªñ¤T­Ó¤ë©|µL¥ô¦ó¯d¨¥
¦n¤Í¦W³æ
©|µL¥ô¦ó¦n¤Í
ºô¯¸³sµ²
©|µL¥ô¦ó³sµ²
¦Û­qÄæ¦ì(¤@)
©|µL¥ô¦ó¤º®e
¯¸¤º·j´M
2006 ¦~ 12 ¤ë 17 ¤é  ¬P´Á¤é   ´¸¤Ñ


¤p¤ß CA-MRSA ¤ÀÃþ: °·±d¥Í¬¡

½ñ¤J¬î©u¡A¦]°®Àê¦ÓÃzµõªº¥Ö½§¡A¹y¦¨¯fµßÂè­ªº·ÅþH¡A³QºÙ¬°¡u¶W¯Å´cµß¡vªºªÀ°Ï©Ê§ÜÃĩʪ÷¶À¸²µå²yµß¡]CA-MRSA¡^¥ç¦³¥i¯à¶X¾÷¸v­h¡A¤µ¦~­Ó®×¤w¸û¥h¦~¥þ¦~¼W¥[¹O­¿¡C½Ã¥Í¨¾Å@¤¤¤ß·P¬V±±¨î³B¥D¥ô¯Îºû¶¯Âå¥Íªí¥Ü¡A¶}©l¦³±wªÌ¥X²{¦h­«§ÜÃĩʡA±¡ªp¥O¤H¾á¼~

½Ã¥Í¨¾Å@¤¤¤ß¤µ¦~±µÀò18©vCA-MRSA§e³ø­Ó®×¡A¸û¥h¦~¥þ¦~ªº7©v¼W¥[ªñ1.6­¿¡A¨ä¤¤¥»¤ë­º¨â©P¤w±µÀò4©v·s­Ó®×¡C¥Ñ©ó¡u´cµß¡vÄݦÛÄ@§e³ø¶Ç¬V¯f¡A¦³Ãö­Ó®×¼Æ¥Ø¨Ã¥¼¤Ï¬M²{¹ê·P¬V±¡úG¡A¾Ú­»´ä¤j¾Ç·P¬V¤Î¶Ç¬V¯f¤¤¤ß¸ê®ÆÅã¥Ü¡A¤µ¦~­º10­Ó¤ëªº²Ö¿n­Ó®×¤w°ª¹F26©v¡A¯f¬r§ó¥X²{5­Ó·sÅܺØ

¯Îºû¶¯±µ¨ü³X°Ý®É«ü¥X¡A¦bÂå°|¥X²{ªº§ÜÃĩʪ÷¶À¸²µå²yµß¡A·P¬V²v¶È0.5¢H¦Ü1%¡A¦ýCA-MRSA«h°ª¹F30%¡A¡u§Y¨Ï¥Ö½§¥u¦³¤p¶Ë¤f¡A¯fµß¤]¥i³y¦¨ÄY­«·P¬V¡A¦~¬ö¤j¡BºC©Ê¯f±wªÌ¸û©ö·P¬V¡A¦ý°·±dªº¦~»´¤H¥ç¨S¦³¨Ò¥~¡v

CA-MRSA§e³ø­Ó®×¤µ¦~¤j´T¼W¥[¡A¦ý¯Îºû¶¯±j½Õ¡u¥»´ä¥¼¥X²{¤j³W¼ÒÃzµo¡v¡A¦]¬°¡u¥Ø«e©Ò±µÀòªº¡A§¡¬O­Ó§O­Ó®×¡A¥¼¦³²Õ¸sÃzµo¡AÁö¦³­Ó®×¬O¸g¥Ñ®a®x¦¨­û¶Ç¬V¡A¦ý¬Ý¤£¥X¬O°ª¦M¸s¡v

¥LÄòºÙ¡A¥Ø«e¤K¦¨CA-MRSA­Ó®×ÄÝ»´·L·P¬V¡A¦p¥Ö½§µoª¢¡B¥ÍÁw½Hµ¥¡A¦ý¤£¯à»´µø¡A¦]¡u´cµß¡v¥iÄÀ©ñ¬r¯À¡A¯}Ãa¥Õ¦å²y¡A´î§C¤HÅé©è§Ü²Óµß¯à¤O¡A¤@¥¹¬r¯À¤J¦å¡A¥i¤Þ°_¸£½¤ª¢¡BÃa¦º©ÊªÍª¢¡A¦º¤`²v°ª¹F¤­¦¨¡A¡u¯fµß³y¦¨ªº¯}Ãa«Ü§Ö¡A¯f¤H¥i¥H¦b¼Æ¤Ñ¤º¦º¤`¡v¡C¥h¦~«K¦³¤@¦W¤k¤l·P¬V¸Óµß«á¦º¤`

CA-MRSA±wªÌ¹ï½L¥§¦èªL¡B«C¾`¯À©MÀYÌUµß¯Àµ¥¤@½u§Ü¥Í¯À§e§ÜÃĩʡA¤@¯ë»Ý¥ÎÃĤO¸û±jªº§Ü¥Í¯ÀªvÀø¡A¨Ò¦p¦h¦èÀô¯À¡]doxycycline¡^¡B¦Ì¿ÕÀô¯À¡]minocycline¡^¤Î§JªL¾`¯À¡]Clindamycin¡^µ¥¡A¦ý·í¯f¬r¡u·U¨Ó·U´c¡v®É¡A³o¨ÇÃÄÀH®É¡uµL®Ä¡v¡C¯Îºû¶¯¥ç³zÅS¡A¥»´ä¦³¤@¦Ü¨â©v­Ó®×ªº±wªÌ¥X²{¦h­«§ÜÃĩʡA±¡ªp¥O¤H¾á¼~

CA-MRSA±aµßªÌ¤@­Ó¼QÀ¡¤]¥i±N´cµß¶Ç¤H¡A¯f¬r§ó¥i¨ÌªþÀô¹Ò¼Æ¤Ñ¡C¯Îºû¶¯ªí¥Ü¡A½ñ¤J¬î©u¡A¥Ö½§¦]°®Àê¦ÓÃzµõ¡A¼W¥[¯fµß·P¬V¾÷·|¡A¥«¥ÁÀ³ª`·N­Ó¤H½Ã¥Í¡A¨Ã§´µ½³B²z¶Ë¤f¡A¤×¨ä²M¼ä¤u¤H¡B«Ø¿v¤u¤H¤Î³½³cµ¥°ª¦M¤H¤h¡AÀ³¸g±`±a¤â®M¡A¥H¨¾¨ü·P¬V¡C½Ã¥Í¸pµy«á¥ç·|¨ì¥þ´ä©Ò¦³Åé¨|³õ©Ò¡A¥H¤Î«Ø³y·~°Ó·|¥[±j«Å¶Ç¤u§@

ªñ¦~¥»´äªºCA-MRSA·P¬V­Ó®×©úÅã¼W¦h¡A¶Ç¬V¯f±M®a¤@ª½¾á¤ß¡u´cµß¡v¦­¤w¦bªÀ°Ï¼çÂáAÀH®É¤@µo¤£¥i¦¬¬B¡C½Ã¥Í¨¾Å@¤¤¤ß·P¬V±±¨î³B¥D¥ô¯Îºû¶¯Âå¥Íªí¥Ü¡A¥¿¿n·¥¬ã¨s§â¡u´cµß¡v¦C¤Jªk©w§e³ø¶Ç¬V¯f¡A³Ì§Ö©ú¦~ªì¸¨¹ê¡C¥t¸p¤è¥ç­p¹º±Nªñ¦~¬y¦æªºO-157¤j¸z±ìµß¤Î´³¯l¶Ë´H¦C¤Jªk©w§e³ø¶Ç¬V¯f¤¤¡A¥H¶i¦æ§óºò±KºÊ¹î

¯Îºû¶¯¸ÑÄÀ¡A¿ð¿ð¥¼±NMRSA¦C¤Jªk©w§e³ø¶Ç¬V¯f¡A¥u¦]¬É©w§e³ø©w¸q»Ý­n¤@¬qªø®É¶¡¡A¡u²{®É¦n¦hÂåÅ@¤H­û¤£»{ÃÑMRSA¡A¤@©w­n¦³²M´·©w¸q¤~¥i±À¦æ¡A©Ò¥H³Ì§Ö¥i±æ©ú¦~ªì¡]¸¨¹ê¡^¡v

¦b¸¨¹ê·s«ü¤Þ«e¡A¨¾Å@¤¤¤ß¤wÂX¤jºÊ´úºôµ¸¡A©ó¥»¤ë¥h«H³qª¾¨p®aÂå¥Í©M«æ¯g«Ç¡A­Yµo²{¯f¤H¦³¤£´M±`¶Ë¤f·P¬V¡A¨Ò¦p¶Ë¤f«ùÄò¬yÁw¤£Â¡µ¥¡A¥i§â¼Ë¥»°e¨ì¬F©²¤ÆÅç«Ç§K¶O¤ÆÅç¡C¥t¥~¡A¥¼½T©w±wªÌ®a¤H¬O§_¦P¼Ë±aµß«e¡AÂåÅ@¤H­û·|¥ý¬£µoÃÄ»I¤©¥L­Ì¡A§h©J¥L­Ì¦b¦Ü¤Ö5¤Ñ¡A¦b»óµÄ¶î¤WÃÄ»I¡A¥H¨¾±N¯f¬r¶Ç¬V¥L¤H

¶Ç¬V¯f±M¬ìÂå¥Í«ü¥X¡A§Y¨Ï¶Ë¤f¬Æ¬°²Ó¤p¡A¦pÀ½À£­±¤Wªº·t½H¡A­Y¤â«ü¬V¦³§ÜÃĩʪ÷¶À¸²µå²yµß¡A³z¹L·t½H¶Ë¤f¶i¤J¥Ö¤U²Õ´µoª¢¡A¤]¥i¥O¨­Åé·P¬VCA-MRSA

½Ã¥Í¸p³Ì·s±µÀòªº·P¬VCA-MRSA¦º¤`­Ó®×¡A±wªÌªì®É¥uµo²{­±³¡¦³¸~µh¡A¦ý«o¦bµo¯f«á5¤é¦º¤`¡C¶Ç¬V¯f±M¬ìÂå¥Í³Ò¥Ã¼Ö¸ÑÄÀ¡A¥Ñ©óCA-MRSA¥i»s³y¬r¯À¡A¯}Ãa¨­Åé´`Àô¨t²Î¡B¤ßŦ¡BµÇŦµ¥¾¹©x¡A¥O¦åÀ£«æ³t¤U­°¡A¥X²{¤¤¬r©Ê¥ð§J¼xª¬¡A­Y¥¼Àò¤Î®É·m±Ï¡A¥i¦b24¦Ü48¤p®É¤º¦º¤`¡A¦º¤`²v°ª¹F¤­¦¨

¬°¥[±j°»´ú¤Î¶EÂ_CA-MRSA¡AÂåºÞ§½ÁÒ¤Uªº«æ¶E«Ç¡A11¤ë°_¥ç¤w®i¶}¤@¶µ°w¹ï©ÊªººÊ¹î­p¹º






³X«È¯d¨¥ (ªð¦^ mervyn ªº¤é»x)

³X«È¦WºÙ¡G
¹q¶l¦a§}¡G (¤£·|¤½¶})
ÅçÃÒ½X¡G  «ö¦¹§ó·sÅçÃÒ½X (¦p¬Ý¤£²M·¡ÅçÃÒ½X½ÐÂIÀ»¹Ï¤ù¨ê·s)
«N«N¸Ü¡G (¥²»Ý µn¤J «á¤~¯à¨Ï¥Î¦¹¥\¯à)
[ ¶}±Ò¦h¥\¯à½s¿è¾¹ ]